Iambic Therapeutics: Funding, Investors & Team (Sep 2026)
Iambic Therapeutics is revolutionizing the healthcare industry with its innovative AI-powered drug discovery platform. With a team of top-notch AI specialists and drug discovery professionals, Iambic has a proven track record of quickly delivering effective therapeutics to the clinic. They are currently developing a pipeline of clinical assets to tackle urgent patient needs. To learn more about Iambic, visit their website at iambic.ai.
Iambic Therapeutics has raised $227M across 3 funding rounds on record, the most recent an undisclosed round of $100M announced in Nov 2025.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Iambic Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Iambic Therapeutics Funding Rounds
Iambic Therapeutics raised $100M in a Series B announced in Oct 2023.
6 months later, an undisclosed round of $26.9M was announced in Apr 2024.
1.6 years later, an undisclosed round of $100M was announced in Nov 2025.
Iambic Therapeutics Founders and Leadership Team
Contact details for the Iambic Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Iambic Therapeutics Funding Compared to Other Artificial Intelligence Startups
Iambic Therapeutics' latest round of $100M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Iambic Therapeutics in Artificial Intelligence and San Diego
Companies Similar to Iambic Therapeutics
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Iambic Therapeutics Funding FAQs
What does Iambic Therapeutics do?
Iambic Therapeutics is revolutionizing the healthcare industry with its innovative AI-powered drug discovery platform. With a team of top-notch AI specialists and drug discovery professionals, Iambic has a proven track record of quickly delivering effective therapeutics to the clinic. They are currently developing a pipeline of clinical assets to tackle urgent patient needs. To learn more about Iambic, visit their website at iambic.ai.
How much funding has Iambic Therapeutics raised?
Iambic Therapeutics has raised $227M across 3 rounds on record. The most recent is an undisclosed round of $100M announced in Nov 2025.
When did Iambic Therapeutics last raise funding?
Iambic Therapeutics' most recent funding round on record is an undisclosed round of $100M, announced in Nov 2025.
Who founded Iambic Therapeutics?
FundedIQ lists Thomas Miller (Founder) at Iambic Therapeutics.
Where is Iambic Therapeutics headquartered?
Iambic Therapeutics is based in San Diego, California, United States.
How many employees does Iambic Therapeutics have?
Iambic Therapeutics is in the 51-100 employee band.
How does Iambic Therapeutics' funding compare to other Artificial Intelligence startups?
Iambic Therapeutics' latest round of $100M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Iambic Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Iambic Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.